Concepedia

Lentinan-functionalized Selenium Nanoparticles target Tumor Cell Mitochondria via TLR4/TRAF3/MFN1 pathway

Huijuan Liu, Yuan Qin, Zihan Zhao, Yang Zhang, Jiahuan Yang, Denghui Zhai, Fang Cui, Ce Luo, Man-Xi Lu, Piao-Piao Liu,

Theranostics · 2020 · 87 citations · 29 references

DOIFull text

Open access

Concepts

Abstract

Selene is a candidate anticancer drug for the treatment of malignant ascites. And TLR4/TRAF3/MFN1 may be a specific nano-drug delivery pathway that could target the mitochondria.

References

29

Pyroptosis

Lieselotte Vande Walle, Mohamed Lamkanfi · Current Biology · 2016 · 633 citations · Full text

The necrosome promotes pancreatic oncogenesis via CXCL1 and Mincle-induced immune suppression

Lena Seifert, Gregor Werba, Shaun Tiwari et al. · Nature · 2016 · 618 citations

, , +10

Cell-Specific and pH-Activatable Rubyrin-Loaded Nanoparticles for Highly Selective Near-Infrared Photodynamic Therapy against Cancer

Jiangwei Tian, Lin Ding, Haijun Xu et al. · Journal of the American Chemical Society · 2013 · 412 citations

, , +17

Pattern and prognostic factors in patients with malignant ascites: a retrospective study

Abraham Ayantunde, SL Parsons · Annals of Oncology · 2007 · 394 citations · Full text

, , +9

MFN1 structures reveal nucleotide-triggered dimerization critical for mitochondrial fusion

Yu-Lu Cao, Shuxia Meng, Yang Chen et al. · Nature · 2017 · 329 citations

, , +12